![]() A small patient sample and lack of valid, specific measures will limit benefit/risk assessment and value communication.Regulatory submissions will require supporting evidence of content validity of primary or key secondary endpoints. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |